Disease/Infection News

RSS

Fibrin immunotherapy may resolve blood clotting induced by SARS-CoV-2

A group of researchers from the United States discovered that the spike glycoprotein of the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) can induce the formation of highly inflammatory blood clots amenable to neutralization by a fibrin-targeting monoclonal antibody – opening the door for a completely new strategy to reduce thrombotic inflammation in coronavirus disease 2019 (COVID-19).

17 Oct 2021

Mix-and-match booster shots beneficial in boosting SARS-CoV-2 immunity

Should you get a second dose of the same vaccine if you’ve received the one-dose Johnson & Johnson shot? According to new clinical trial results published on the preprint medRxiv* server, a booster shot of a messenger RNA (mRNA) vaccine may increase your chances of neutralizing severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2).

17 Oct 2021

Researchers identify common side effects of three COVID-19 vaccines

COVID-19 vaccines remain the best tool in the pandemic toolbox against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). But they are not perfect; reports have surfaced of mild to severe side effects after vaccination. A new study from researchers in the Lampe & Company GmbH & Co. KG compared the severity of adverse events from each coronavirus vaccine.

17 Oct 2021

Public health interventions, more hospitals associated with reduction in COVID-19 case-fatality rates

Counties that banned in-person religious gatherings and those with a greater number of hospitals per capita were associated with a decreased case-fatality rate of COVID-19 during the pandemic’s first wave, according to a new University of Michigan study.

15 Oct 2021

New protocol reduces hospitalizations, deaths of liver and kidney transplant patients with COVID-19

Liver and kidney transplant recipients have a higher risk of severe COVID-19 and/or death should they become infected because the medication they take to ensure a successful transplant suppresses their immune systems.

15 Oct 2021

Metabolic restoration as a therapeutic approach to promote natural immune protection against HIV

The human immunodeficiency virus (HIV-1) particularly attacks CD4 lymphocytes, a type of white blood cell considered to be the conductor of the immune system.

15 Oct 2021

New risk measure can better predict pandemic spread than other models

COVID-19 is not the flu. The disease caused by the novel SARS-CoV-2 virus is more transmissible, and deadlier, than most influenza epidemics we've encountered in our lifetimes, and scientists and physicians are still learning new things about the disease and its long-term effects.

15 Oct 2021

Global progress in tackling tuberculosis has been reversed by the COVID-19 pandemic

The COVID-19 pandemic has reversed years of global progress in tackling tuberculosis and for the first time in over a decade, TB deaths have increased, according to the World Health Organization's 2021 Global TB report.

15 Oct 2021

New wearable and noninvasive device created for less intrusive glucose monitoring

Noninvasive glucose monitoring devices are not currently commercially available in the United States, so people with diabetes must collect blood samples or use sensors embedded under the skin to measure their blood sugar levels.

15 Oct 2021

Study: Statin treatment slightly lowers COVID-19 mortality

Statins are a recommended and common intervention for preventing cardiovascular events by reducing levels of lipoprotein cholesterol in the blood. During the pandemic, it has been debated whether statins influence the risk of death from COVID-19.

15 Oct 2021

Phase 1 open-label trial shows SARS-CoV-2 DNA vaccine induces durable immune response

The efficacy and safety of a DNA-based vaccine are investigated, finding that the unique vaccine imparts a robust and long-lasting immunogenic response.

15 Oct 2021

Phase 2 study shows safety and immunogenicity of SARS-CoV-2 recombinant protein vaccine

The results of a phase 2 clinical trial featuring a SARS-CoV-2 recombinant protein vaccine developed by GlaxoSmithKline are reported, demonstrating a favorable immune response amongst both naïve and non-naïve adults with an acceptable safety profile.

15 Oct 2021

The military as a disease vector and COVID-19

A recent systematic review aimed to study existing evidence for the military being a historically relevant disease vector that has been overlooked during the COVID-19 pandemic.

15 Oct 2021

Study detects the presence of SARS-CoV-2 in semen along with low sperm count

A new study reported findings of semen analysis from a prospective COVID-19 cohort study.

15 Oct 2021

Study finds menstrual bleeding changes after SARS-CoV-2 vaccination

A new study investigated menstrual bleeding patterns among current and former menstruating people, based on the premise that these bleeding changes were associated with changes in clotting or inflammation, which can affect the normal menstrual repair.

15 Oct 2021

Disease/Infection News

Fibrin immunotherapy may resolve blood clotting induced by SARS-CoV-2

Mix-and-match booster shots beneficial in boosting SARS-CoV-2 immunity

Researchers identify common side effects of three COVID-19 vaccines

Public health interventions, more hospitals associated with reduction in COVID-19 case-fatality rates

New protocol reduces hospitalizations, deaths of liver and kidney transplant patients with COVID-19

Metabolic restoration as a therapeutic approach to promote natural immune protection against HIV

New risk measure can better predict pandemic spread than other models

Global progress in tackling tuberculosis has been reversed by the COVID-19 pandemic

New wearable and noninvasive device created for less intrusive glucose monitoring

Study: Statin treatment slightly lowers COVID-19 mortality

Phase 1 open-label trial shows SARS-CoV-2 DNA vaccine induces durable immune response

Phase 2 study shows safety and immunogenicity of SARS-CoV-2 recombinant protein vaccine

The military as a disease vector and COVID-19

Study detects the presence of SARS-CoV-2 in semen along with low sperm count

Study finds menstrual bleeding changes after SARS-CoV-2 vaccination

NIH RADx initiative announces $77.7 million to develop new rapid COVID-19 diagnostic tests

Lateral flow tests are more accurate at detecting Covid-19 than previously reported

New program could be added to the COVID alert app to improve vaccination campaigns

Scientists testify the importance of timely influenza vaccination

Nasal photodisinfection therapy for COVID-19 patients may reduce the severity of lower tract respiratory disease

Advancing brain microphysiological systems (bMPS)

PhD researcher at LifeArc

Unveiling Hidden Potential: Organoids for Disease Modeling in Neuroscience Research

Latest News